Raymond James & Associates’s Lantern Pharma LTRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-25,879
Closed -$289K 4035
2021
Q3
$289K Buy
+25,879
New +$289K ﹤0.01% 3420